FinancingsArGen-X BV raised $37.1 million in a Series B round.Celsion Corp. is raising $15 million in a private placement of stock and warrants.Inhibitex Inc. raised $20 million through an at-the-market offering.NuCana BioMed Ltd. raised $10.5 million in a Series A round for anticancer nucleoside analogues.Oxigene Inc. established a $20 million standby equity purchase agreement.